✦ LIBER ✦

Expression of Survivin, Mutant p53 and C-erbB-2 in Breast Cancer and Its Clinical Significance

✍ Scribed by Huihua XIONG; Shiying YU; Shu XIA; Liang ZHUANG

Publisher: Springer
Year: 2005
Tongue: English
Weight: 113 KB
Volume: 4
Category: Article
ISSN: 1610-1979
DOI: 10.1007/s10330-004-0299-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PROGNOSTIC SIGNIFICANCE OF THE CO-EXPRES

PROGNOSTIC SIGNIFICANCE OF THE CO-EXPRESSION OF p53 AND c-erbB-2 PROTEINS IN BREAST CANCER

✍ NAKOPOULOU, LYDIA L.; ALEXIADOU, ANASTASIA; THEODOROPOULOS, GEORGE E.; LAZARIS, 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 814 KB

The immunohistochemical expression of p53 and c-erbB-2 gene proteins was examined in a series of 130 breast adenocarcinomas. This study intended to investigate whether the frequency of the altered expression of the tumour suppressor gene p53 and the overexpression of the oncogene c-erbB-2 in breast

The expressions and clinical significanc

The expressions and clinical significance of P53, C-erbB-2 and VEGF in non-small cell lung cancer

✍ Aiqin Gu; Yu Xin; Gang Chen; Baohui Han; Hao Ji; Bo Yan 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 77 KB

Expression of c-erbB2 in gestational tro

Expression of c-erbB2 in gestational trophoblastic disease and its clinical significance

✍ Wang Yuxia; Cao Yang; Sun Yongyu 📂 Article 📅 2002 🏛 Springer-Verlag 🌐 Chinese ⚖ 671 KB

Expression of c-erbB2 and p53 protein is

Expression of c-erbB2 and p53 protein is similar in breast cancer from British and Japanese women

✍ William J. Merchant; Rosemary R. Millis; Paul Smith,; Murid A. Chaudary; Diana M 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 93 KB 👁 2 views

Angiogenesis, p53, and c-erbB-2 immunore

Angiogenesis, p53, and c-erbB-2 immunoreactivity and clinicopathological features in male breast cancer

✍ Baruch Shpitz; Yonit Bomstein; Ahud Sternberg; Ehud Klein; Sigal Liverant; Gabri 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB 👁 1 views

No significant predictive value of c- er

No significant predictive value of c- erbB-2 or p53 expression regarding sensitivity to primary chemotherapy or radiotherapy in breast cancer

✍ Sylvie Rozan; Anne Vincent-Salomon; Brigitte Zafrani; Pierre Validire; Patricia 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 325 KB 👁 2 views

To document whether c-erbB-2 over-expression or p53 accumulation in tumour cells was predictive of response to chemo-or radiotherapy, we analyzed a population of patients with breast cancer assigned to neo-adjuvant therapy (median follow-up: 54 months). T2/T3-N0N1b-M0 tumours (329 cases) were treate